High grade and metastatic brain tumours exhibit considerable spatial variations in proliferation, angiogenesis, invasion, necrosis and oedema. Vascular heterogeneity arising from vascular cooption in regions of invasive growth (in which the blood-brain barrier remains intact) and neoangiogenesis is a major challenge faced in the assessment of brain tumours by conventional MRI.
The effective treatment of brain tumours is an unmet and urgent clinical need. Five year survival for patients with grade IV glioma (glioblastoma, GBM) is only 5%. 1 While patients with low grade gliomas have a better prognosis, there is, as yet, no assured cure using conventional therapies. Patients with brain metastases, which affect approximately 8-10% of cancer patients and approximately 30% of patients with breast cancer, have a similarly poor prognosis. 2, 3 High grade and metastatic brain tumours exhibit considerable spatial heterogeneity in gene expression and biochemistry, resulting in regional differences in tumour cell and microvascular proliferation, angiogenesis, necrosis and invasion. Diffuse infiltration of tumour cells in the neuropil, the dense network of interwoven neuronal and glial cell processes, is a characteristic of both low and high grade brain tumours, 4 and its clinical management is one of the greatest challenges facing neuro-oncologists and radiologists treating patients with brain tumours.
Imaging biomarkers for the assessment of tumour pathophysiology and response to therapeutics are now widespread in the clinic, and diagnostic imaging is an essential tool in the treatment stratification of patients with brain tumours. MRI enables the visualization of detailed anatomical features with high resolution due to its exquisite soft tissue image contrast, 5 and is therefore the imaging methodology of choice for defining brain tumour anatomy and delineating tumours.
Advanced MRI also provides a means of defining quantitative biomarkers to inform on biologically relevant structure-function relationships in tumours, enabling an understanding of the behaviour and heterogeneous distribution of such associations. 6 There is a pressing need for refined MRI strategies and quantitative biomarkers to accurately interrogate specific growth patterns associated with infiltrative intracerebral tumours.
Conventional gadolinium-enhanced MRI, which is used exten- have been used extensively pre-clinically to delineate blood vessels and to provide estimates of fractional tumour blood volume and vessel calibre. [7] [8] [9] USPIO-enhanced MRI, alone or in combination with gadolinium-enhanced MRI, may therefore enable delineation of vessels within glioma regions with an intact BBB within co-optive, infiltrative areas.
We hypothesized that functional MRI, incorporating assessment of vascular parameters and diffusion characteristics, can report on heterogeneity within infiltrative brain tumours and inform on functionally diverse habitats. We employed a multiparametric MRI approach incorporating native measurements and both Gd-DTPA-and USPIOenhanced imaging, and assessed the data using histogram and unsupervised cluster analysis, to examine the spatial distribution of vascular permeability and volume, diffusion characteristics and invasion in RG2 and MDA-MB-231 LM2-4 intracranial tumours in vivo. ) mice (Charles River, Margate, UK), as previously described.
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A total of 13 RG2 and 14 MDA-MB-231 LM2-4 tumour bearing mice were used in this study. 
| Bioluminescence imaging

| MRI data analysis
Parameter estimation was undertaken using a Bayesian maximum a posteriori algorithm, which took into account the Rician distribution of noise in magnitude MR data in order to provide unbiased parameter estimates. 14, 15 Estimates of the apparent diffusion coefficient
) were determined from the EPI-DWI data.
The dual relaxation rate sensitivity of the IR-trueFISP sequence was utilized to provide estimates of both the native longitudinal and transverse relaxation times, T 1 and T 2 (ms). The change in R 1 (=1/T 1 , ΔR 1 , ms
) following delivery of Gd-DTPA was also evaluated. The transverse relaxation rate R 2 * (s
) was quantified using the MGE data, and the USPIO-induced change in R 2 * (ΔR 2 *) was used to estimate fractional blood volume (fBV, %), using the following equation 7, 16 :
where Δχ, the change in susceptibility induced by USPIO, was taken to equal 0.408 ppm, the Larmor frequency of protons (γ) taken to equal 4.26 × 10 7 s −1 T −1 and the static magnetic field strength B 0 = 7 T. The value of Δχ is valid for the dose of USPIO contrast agent used in vivo in mice. 7 Pixels corresponding to an fBV exceeding 17%
(the limit value for the linearity between ΔR 2 * and fBV) 17 were excluded. All data were fitted on a pixel-by-pixel basis using in-house 
| Cluster analysis
Unsupervised cluster analysis was performed using in-house software developed in IDL. The k-means algorithm was employed to partition the ROIs into sub-regions of similar characteristics, defined in the two-dimensional (2D) feature space formed by the two parameters ΔR 1 and fBV, ΔR 1 and ADC, or fBV and ADC, and the three-dimensional (3D) feature space formed by all three parameters. 18 The optimal number of clusters for each dataset was determined using the cluster validation method described by Sugar and James. 
| Statistical analysis
Statistical analysis was performed using GraphPad Prism (GraphPad Figure 1A . The quantitative MRI data for tumour and uninvolved brain ROIs is summarized in Table 1 .
RG2 tumours revealed a more homogeneous appearance on T 2 - Figure S1a) . In order to eliminate this cluster and optimize the utility of the cluster analysis, a threshold was applied to each dataset, defined as the value below which a data point had only a 5% probability of belonging to the 'outlier' cluster, yielding thresholds 
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A key issue at the outset of this study was the application of our multiparametric MRI strategy in intracranial tumour models displaying include those vessels that are not perfused, but may also correspond to areas with a low density of mature, relatively impermeable vessels, likely areas where the native vessels have been co-opted in regions of invasion. 31 Indeed, these voxels, particularly in the MDA-MB-231 LM2-4 tumours, were predominantly located at the tumour margin, where tumour cell invasion was identified on H&E-stained sections.
Regions with high fBV had either more densely packed or larger calibre vessels, resulting in a relatively larger blood volume. Regions where both parameters were high, which only formed a separate cluster in the RG2 tumours (green), probably correspond to regions with either extensive neovasculature or large distended vessels. 32 MRI protocols incorporating two vascular contrast agents, either an iron oxide preparation in combination with a gadolinium-based agent, or sequential injection of low and then high molecular weight gadolinium-based agents, performed either in the same imaging session or separated by hours, have previously been used to assess tumour vasculature in intracranial tumour models in rats and mice, [33] [34] [35] [36] [37] and for assessing response to anti-angiogenic treatment in melanoma xenografts in mice. 38 The key advantage of the imaging strategy used herein is that it enabled the spatial analysis of how . 2D projections of the clustered 3D voxel distribution are shown in Figure b . B, Corresponding cluster analysis maps of RG2 and MDA-MB-231 LM2-4 tumours; where data thresholding was applied, these values are removed from the maps. Voxels without an evaluable fBV (negative ΔR 2 *) are also missing from analyses incorporating fBV. C, H&E staining of the same tumours shows spatial relationships between cluster analysis maps and the tumour physiology. The closed head arrow denotes region of invasion along blood vessels and oedema, the open head arrow denotes invasion without oedema and the dashed arrow denotes main dense tumour mass gadolinium-based contrast agents in the same imaging session in adults with primary brain cancer or brain metastases, and in children with brain tumours. 41 Studies such as these, which incorporate methods similar to those used in this study, may guide the creation of new imaging criteria/biomarkers to evaluate brain tumour progression and pseudo-progression secondary to radio-chemotherapy and antiangiogenic agents.
Susceptibility contrast MRI exploits negative contrast induced by USPIO particles, which inherently reduce signal-to-noise ratios (SNRs).
The Bayesian maximum a posteriori model used herein provides a thorough treatment of data point estimates of R 2 * involving representation of the associated uncertainties. For susceptibility contrast MRI it allows the determination of the significance of differences in R 2 * between two or more measurements, and consequently the probability that ΔR 2 * is greater than or less than zero on a pixel-by-pixel basis in vivo can be estimated. 14 This method represents a more stringent calculation of MRI parameters when SNR is modest or low. Susceptibility artefacts as a result of the air-tissue interface can emerge in MGE images, but any data affected by such artefacts were excluded from analysis in this study.
We were interested to find that, whilst susceptibility contrast MRI-derived measurements of tumour fBV have previously been validated against uptake of the Hoechst 33342 perfusion marker 42 and oedema. 45 The routine incorporation of DW imaging to gadolinium-enhanced imaging protocols in the clinic may thus assist in the more accurate resolution and characterisation of these brain tumour regions. 46 Multiparametric MRI, focussing particularly on the microvasculature, was used by Coquery et al. to establish MRI-derived clusters to characterize tumour heterogeneity, and correlate them to pathophysiological features, in rat brain tumour models. 25 MRI-based brain tumour segmentation to separate different tumour subcompartments from normal brain structures has been largely performed using supervised learning techniques, which are time consuming and expensive due to the requirement of teaching datasets and labelled images. 47 Unsupervised methods are now increasingly being developed and have been shown to perform well in comparison with supervised techniques. 24 Of particular importance is the segmentation of non-enhancing tumour from healthy tissue to monitor tumour size more accurately over time. 48 Further refinements in these techniques include 3D histogram analysis of routinely acquired images to identify radiologically defined regional habitat variations in brain tumour data to provide deeper insight into the evolutionary dynamics of brain tumours, 22 
